93 related articles for article (PubMed ID: 9143298)
1. An equine herpesvirus-1 gene 71 deletant is attenuated and elicits a protective immune response in mice.
Marshall KR; Sun Y; Brown SM; Field HJ
Virology; 1997 Apr; 231(1):20-7. PubMed ID: 9143298
[TBL] [Abstract][Full Text] [Related]
2. Equine herpesvirus 1 mutants devoid of glycoprotein B or M are apathogenic for mice but induce protection against challenge infection.
Neubauer A; Beer M; Brandmüller C; Kaaden OR; Osterrieder N
Virology; 1997 Dec; 239(1):36-45. PubMed ID: 9426444
[TBL] [Abstract][Full Text] [Related]
3. Protection against EHV-1 challenge infection in the murine model after vaccination with various formulations of recombinant glycoprotein gp14 (gB).
Osterrieder N; Wagner R; Brandmüller C; Schmidt P; Wolf H; Kaaden OR
Virology; 1995 Apr; 208(2):500-10. PubMed ID: 7747423
[TBL] [Abstract][Full Text] [Related]
4. [Mutations in the US2 and glycoprotein B genes of the equine herpesvirus 1 vaccine strain RacH have no effects on its attenuation].
Neubauer A; Meindl A; Osterrieder N
Berl Munch Tierarztl Wochenschr; 1999 Sep; 112(9):351-4. PubMed ID: 10507185
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo characterization of equine herpesvirus type 1 (EHV-1) mutants devoid of the viral chemokine-binding glycoprotein G (gG).
von Einem J; Smith PM; Van de Walle GR; O'Callaghan DJ; Osterrieder N
Virology; 2007 May; 362(1):151-62. PubMed ID: 17250864
[TBL] [Abstract][Full Text] [Related]
6. The pathogenesis of ED71, a defined deletion mutant of equine herpesvirus-1, in a murine intranasal infection model for equine abortion.
Fitzmaurice T; Walker C; Kukreja A; Sun Y; Brown SM; Field HJ
J Gen Virol; 1997 Sep; 78 ( Pt 9)():2167-9. PubMed ID: 9292003
[TBL] [Abstract][Full Text] [Related]
7. An equine herpesvirus type 1 recombinant with a deletion in the gE and gI genes is avirulent in young horses.
Matsumura T; Kondo T; Sugita S; Damiani AM; O'Callaghan DJ; Imagawa H
Virology; 1998 Mar; 242(1):68-79. PubMed ID: 9501037
[TBL] [Abstract][Full Text] [Related]
8. Growth of recombinant equine herpesvirus 1 (EHV-1) replaced with passage-induced mutant gene 1 and gene 71 derived from an attenuated EHV-1 in cell cultures and in the lungs of mice.
Kirisawa R; Kobayashi T; Uematsu R; Ikeda A; Kuroiwa R; Urakami A; Iwai H
Vet Microbiol; 2003 Sep; 95(3):159-74. PubMed ID: 12935744
[TBL] [Abstract][Full Text] [Related]
9. Use of DNA and recombinant canarypox viral (ALVAC) vectors for equine herpes virus vaccination.
Minke JM; Fischer L; Baudu P; Guigal PM; Sindle T; Mumford JA; Audonnet JC
Vet Immunol Immunopathol; 2006 May; 111(1-2):47-57. PubMed ID: 16580075
[TBL] [Abstract][Full Text] [Related]
10. The open reading frames 1, 2, 71, and 75 are nonessential for the replication of equine herpesvirus type 1 in vitro.
Sun Y; Brown SM
Virology; 1994 Mar; 199(2):448-52. PubMed ID: 8122373
[TBL] [Abstract][Full Text] [Related]
11. Equine herpesvirus 1 glycoprotein D expressed in E. coli provides partial protection against equine herpesvirus infection in mice and elicits virus-neutralizing antibodies in the horse.
Weerasinghe CU; Learmonth GS; Gilkerson JR; Foote CE; Wellington JE; Whalley JM
Vet Immunol Immunopathol; 2006 May; 111(1-2):59-66. PubMed ID: 16473414
[TBL] [Abstract][Full Text] [Related]
12. Serum antibody responses to equine herpesvirus 1 glycoprotein D in horses, pregnant mares and young foals.
Foote CE; Love DN; Gilkerson JR; Rota J; Trevor-Jones P; Ruitenberg KM; Wellington JE; Whalley JM
Vet Immunol Immunopathol; 2005 May; 105(1-2):47-57. PubMed ID: 15797474
[TBL] [Abstract][Full Text] [Related]
13. A protective effect of epidermal powder immunization in a mouse model of equine herpesvirus-1 infection.
Kondo T; McGregor M; Chu Q; Chen D; Horimoto T; Kawaoka Y
Virology; 2004 Jan; 318(1):414-9. PubMed ID: 14972566
[TBL] [Abstract][Full Text] [Related]
14. Immunisation of Balb/c mice with severely attenuated murine cytomegalovirus mutants induces protective cellular and humoral immunity.
Morley PJ; Ertl P; Sweet C
J Med Virol; 2002 Jun; 67(2):187-99. PubMed ID: 11992579
[TBL] [Abstract][Full Text] [Related]
15. The equine herpesvirus 1 IR6 protein influences virus growth at elevated temperature and is a major determinant of virulence.
Osterrieder N; Neubauer A; Brandmüller C; Kaaden OR; O'Callaghan DJ
Virology; 1996 Dec; 226(2):243-51. PubMed ID: 8955044
[TBL] [Abstract][Full Text] [Related]
16. Immunization with Attenuated Equine Herpesvirus 1 Strain KyA Induces Innate Immune Responses That Protect Mice from Lethal Challenge.
Kim SK; Shakya AK; O'Callaghan DJ
J Virol; 2016 Sep; 90(18):8090-104. PubMed ID: 27356904
[TBL] [Abstract][Full Text] [Related]
17. Immune responses to commercial equine vaccines against equine herpesvirus-1, equine influenza virus, eastern equine encephalomyelitis, and tetanus.
Holmes MA; Townsend HG; Kohler AK; Hussey S; Breathnach C; Barnett C; Holland R; Lunn DP
Vet Immunol Immunopathol; 2006 May; 111(1-2):67-80. PubMed ID: 16476488
[TBL] [Abstract][Full Text] [Related]
18. Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo.
Pushko P; Parker M; Ludwig GV; Davis NL; Johnston RE; Smith JF
Virology; 1997 Dec; 239(2):389-401. PubMed ID: 9434729
[TBL] [Abstract][Full Text] [Related]
19. Interactions between equine herpesvirus type 1 and equine herpesvirus type 4: T cell responses in a murine infection model.
Azmi M; Field HJ
J Gen Virol; 1993 Nov; 74 ( Pt 11)():2339-45. PubMed ID: 8245851
[TBL] [Abstract][Full Text] [Related]
20. Equine herpesvirus-1 strain KyA, a candidate vaccine strain, reduces viral titers in mice challenged with a pathogenic strain, RacL.
Colle CF; Tarbet EB; Grafton WD; Jennings SR; O'Callaghan DJ
Virus Res; 1996 Aug; 43(2):111-24. PubMed ID: 8864201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
